Paul Berg Net Worth & Insider Trades

Paul Berg - Director, Gilead Sciences Inc

As of May 13, 2011

What is Paul Berg's Net Worth?

The current estimated net worth of Gilead Sciences Inc's Director, Paul Berg, is estimated to be about $31.3M . Paul Berg owns about 32,000 units of Gilead Sciences Inc common stock. In the last 8 years at Gilead Sciences Inc, Paul Berg has sold an estimated value of $31.07M worth.

What is Paul Berg's Past Insider Trading?

Paul Berg's largest purchase order was 50,000 units , worth over $785K on November 24, 2010. Paul Berg's largest sale order was 50,000 units , worth over $1.87M on November 24, 2010. In total, Paul Berg has made about 72 transactions over 8 years of their time at Gilead Sciences Inc. Paul Berg usually trades in May, with the busiest year in 2008. The most recent transaction was a sale order of 20,000 units , worth over $738.57K on December 16, 2010.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Paul Berg's' Mailing Address?

  • Mailing address is Stanford University School of Medicine #b062 Stanford CA 94305 CA

What are Gilead Sciences Inc's Past Insider Trades?

Gilead Sciences Inc's most recent insider trade came on March 14, 2022 by Brett A Pletcher who sold 5,723 units worth $332.64K . In the last 19 years, insiders at Gilead Sciences Inc have sold an estimated value of $2.75B and bought an estimated value of $524.22M worth of shares. Insider trading is most common in May, with the busiest year in 2014 and 2015. The most active traders at the company are Gregg H Alton, Chief Patient Officer,  John C Martin, Director,  and John F Milligan, President and CEO .

GILEAD SCIENCES, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1